Company Filing History:
Years Active: 2024
Title: The Innovations of Kartrin Partikel
Introduction
Kartrin Partikel is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on substituted S-alaninate derivatives. His research focuses on developing new treatments for vascular disorders, which are critical for improving patient outcomes.
Latest Patents
Kartrin Partikel holds one patent for his invention titled "Substituted S-alaninate derivatives." This patent details the processes for preparing these derivatives and their applications in creating medicaments aimed at treating and preventing diseases, especially thrombotic or thromboembolic disorders. The implications of his work are substantial, as they offer potential solutions for serious health issues.
Career Highlights
Partikel is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts. His work is recognized for its potential impact on therapeutic strategies.
Collaborations
Some of his notable coworkers include Hartmut Beck and Stefanie Mesch. Their collaboration enhances the research environment, fostering innovation and the development of new therapeutic solutions.
Conclusion
Kartrin Partikel's contributions to medicinal chemistry through his patent on substituted S-alaninate derivatives highlight his role as an influential inventor. His work at Bayer Aktiengesellschaft exemplifies the importance of innovation in addressing complex health challenges.